English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Pro

Presents the zaia usage as premium feature

ZAIA

Presents AI Discovery search usage as a premium feature

AI Discovery

Presents AI Discovery explain and summary usage as a premium feature

Content Analysis

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Presents the pdf analysis as premium feature

PDF Analysis

1500 Top-up

3000 Top-up

Zendy Basic

2500 Top-up

Zendy Unlimited

Presents the access of premium content as premium feature

Premium Content

Transcatheter aortic valve implantation (TAVI) has become a safe and valid procedure in all surgical risk patients, expanding TAVI indications to a larger number of patients. However, while shortand mid-term follow up showed similar results compared to surgery, long-term durability remains unstudied. Concerns about TAVI longevity are mainly raised by early development of higher rates of bioprosthetic valve disfunction (BVD) and especially of paravalvular leaks (PVL), which have been previously related with long-term mortality. In this context, the definition of BVD, its relationship with the TAVI technology (balloon vs. self-expandable), and the prognostic role of mild PVL are a complex topic which has not been clarified yet, along with outcomes of valve-in-valve (ViV) intervention, which represents a valid therapeutic option in the case of severe BVD. The aim of this narrative review is to offer a general overview of the evolution of TAVI indications; show the differences between balloon and self-expandable prostheses performances; clarify the definition, classification, and prognostic role of BVD; and summarize current evidence about long-term TAVI durability.

Durability of transcatheter aortic valves, current evidence and future prospective